DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 8.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 353,194 shares of the medical instruments supplier’s stock after acquiring an additional 27,708 shares during the quarter. Thrivent Financial for Lutherans owned about 0.17% of DENTSPLY SIRONA worth $8,798,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Wahed Invest LLC raised its stake in DENTSPLY SIRONA by 9.3% during the 4th quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock valued at $128,000 after acquiring an additional 306 shares during the last quarter. Raymond James Trust N.A. lifted its holdings in shares of DENTSPLY SIRONA by 4.9% during the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock worth $241,000 after purchasing an additional 453 shares during the period. LRI Investments LLC grew its position in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the last quarter. Diversified Trust Co increased its stake in DENTSPLY SIRONA by 3.0% in the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock valued at $489,000 after buying an additional 566 shares during the period. Finally, Envestnet Portfolio Solutions Inc. raised its position in DENTSPLY SIRONA by 6.6% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 10,748 shares of the medical instruments supplier’s stock worth $357,000 after buying an additional 662 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on XRAY shares. Barrington Research reiterated an “outperform” rating and set a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Stifel Nicolaus cut their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and an average target price of $33.22.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $25.73 on Thursday. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $5.34 billion, a P/E ratio of -58.48, a price-to-earnings-growth ratio of 1.26 and a beta of 1.00. The firm has a 50-day moving average price of $25.52 and a two-hundred day moving average price of $27.70. DENTSPLY SIRONA Inc. has a twelve month low of $23.58 and a twelve month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. During the same period last year, the business earned $0.51 earnings per share. The company’s revenue for the quarter was down 4.3% on a year-over-year basis. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.